EndoSee Corp., a Los Altos, California company, is seeking to raise $2.5 million to commercialize an investigational device that makes office hysteroscopy possible.
The company has already raised $1.6 million.
The Funding Model for Cancer Innovation is Broken — We Can Fix It
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.
Hysteroscopy involves evaluation of the uterine cavity, including the endometrium using endoscopic tools. A hysteroscope can be used to detect endometrial polyps and other gynecological problems.. Generally, hysteroscopy is performed in a hospital and surgical centers, but office hysteroscopy is also possible.
EndoSee’s investigational device allows the procedure to be done at an OB-GYN’s office. EndoSee’s hysteroscope is a handheld device that has a screen about the size of an smartphone which has an integrated camera. Conventional hysteroscopes need external lighting and display the image on a separate computer screen.
According to the regulatory filing, EndoSee’s officers are Dr. Paul Indman, a gynecologist, Shih-Ping(Bob) Wang and Xialong (Bruce) OuYang and Kevin Rooney.